SPOTLIGHT -
Are You Attending the 2024 APSARD Conference?
Ann Childress, MD, the current president of APSARD, invites you to attend this year's conference!
Positive Top-Line Phase 3 Data on Novel ADHD Treatment, CTx-1301
New positive data for novel ADHD treatment.
A Welcome Addition to the Child and Adolescent ADHD Armamentarium
This new medication is a huge leap forward for treating attention-deficit/hyperactivity disorder.
The Future of the ADHD Treatment Landscape
Stimulant Abuse in Pediatric ADHD Populations
Unmet Needs in Pediatric ADHD Management
Medicine Management During COVID-19 Pandemic
Practical Advice for Caregivers During COVID-19 Pandemic
The Impact of COVID-19 Pandemic on Pediatrics
Managing ADHD During the COVID-19 Pandemic
Collaborative Management: Pediatricians and Psychiatrists
Screening for ADHD and Comorbidities
Academy of Pediatrics Clinical Practice Guidelines